Medication info
Telmito Plus 80/12.5 mg Tablets

Telmito Plus 80/12.5 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›80mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Il Sung I.S. Co., Ltd.
Appearance
Oval tablets consisting of two layers, white and pink, may have pink spots on the white layer.
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201000949 · Notified 2010.01.28 · Insurance code 655402890

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this drug, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted separately. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this drug. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This drug should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This drug should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this drug should not exceed 40/12.5mg. This drug should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.
Child dose
The safety and efficacy of this drug have not been established in children under 18 years of age.

Ingredients

Manufacturer
Il Sung I.S. Co., Ltd.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

This medication is used in the treatment of essential hypertension. It may effectively improve blood pressure in patients whose blood pressure is not adequately controlled by telmisartan alone.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this drug, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted separately. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this drug. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This drug should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This drug should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this drug should not exceed 40/12.5mg. This drug should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.

Child dose

The safety and efficacy of this drug have not been established in children under 18 years of age.

Precautions

This medication can pose serious risks to the fetus during pregnancy, especially in the second and third trimesters, and must be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals allergic to any of its components or those with certain liver or kidney diseases. Caution is advised in elderly patients or those with high potassium levels or impaired liver function, as well as in patients with heart diseases or gastrointestinal disorders. The hydrochlorothiazide component may affect the body's electrolyte balance, potentially causing hypokalemia, hyperkalemia, hyponatremia, and other electrolyte disturbances, so regular blood tests are required. This medication may cause skin reactions that are sensitive to sunlight, so patients should avoid UV exposure and take care of skin protection during treatment. Interactions may occur when taken with other antihypertensives, certain diuretics, lithium, potassium supplements, etc., so consultation with a doctor is essential. Symptoms such as dizziness or drowsiness may occur when driving or operating machinery, so caution is required. Overdose may lead to hypotension, electrolyte imbalance, and dehydration, requiring immediate medical assistance. It is not recommended for children or adolescents under 18 years of age as safety and efficacy have not been established.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorder
Show 117 more
  • dizziness
  • fainting
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver function abnormalities
  • liver disorders
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasm
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased serum uric acid
  • increased serum creatinine
  • increased creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • taste disturbance
  • eczema
  • drug rash
  • toxic skin rash
  • bone pain
  • renal dysfunction
  • myasthenia
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • myasthenia
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremor
  • facial flushing
  • malaise
  • fatigue
  • proteinuria
  • itching
  • myalgia
  • a feeling of floating
  • tremor of lips and hands
  • sensory hypersensitivity
  • decreased vision
  • hypotension
  • tachycardia
  • bradycardia
  • acute respiratory distress syndrome
  • pancreatitis
  • angioedema
  • vasculitis
  • acute myopia
  • angle-closure glaucoma
  • choroidal exudate
  • acute respiratory distress syndrome
  • intestinal vascular edema

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is best to maintain a storage temperature between 1 and 30 degrees Celsius. This will safely preserve the medication's effectiveness.

Appearance and packaging

Appearance

Oval tablets consisting of two layers, white and pink, may have pink spots on the white layer.

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.